D3AHeader code — not billable
Benign neuroendocrine tumors
- Chapter
- 2. Neoplasms
- Category
- D3A
- Effective date
- October 1, 2026
Related codes in category D3A
D3A.0Benign carcinoid tumorsD3A.00Benign carcinoid tumor of unspecified siteYesD3A.01Benign carcinoid tumors of the small intestineD3A.010Benign carcinoid tumor of the duodenumYesD3A.011Benign carcinoid tumor of the jejunumYesD3A.012Benign carcinoid tumor of the ileumYesD3A.019Benign carcinoid tumor of the small intestine, unsp portionYesD3A.02Benign carcinoid tumors of the appendix, lg int, and rectumD3A.020Benign carcinoid tumor of the appendixYesD3A.021Benign carcinoid tumor of the cecumYesD3A.022Benign carcinoid tumor of the ascending colonYesD3A.023Benign carcinoid tumor of the transverse colonYes
Frequently asked questions
What is ICD-10 code D3A?
D3A is an ICD-10-CM diagnosis code for Benign neuroendocrine tumors.
Is D3A a billable code?
No. D3A is a category/header code, not billable on its own — use one of its more specific child codes instead.
What ICD-10-CM chapter is D3A in?
D3A falls under Chapter 2: Neoplasms.
When did D3A become effective?
D3A has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.
What other codes are related to D3A?
D3A belongs to category D3A, which includes 12 other codes — see the related codes list on this page.
ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.